drugset

drugset / Trial / NCT06345885

Immunogenicity and Safety of One Dose of HPV Vaccine

NCT06345885 ↗

Phase 4 Completed 200 enrolled Xiamen Innovax Biotech Co., Ltd

RandomizedParallel-groupOpen-labelPrevention

Summary

This study will assess the immunogenicity and safety of one dose of Cecolin and one dose of Gardasil

Timeline

Start: 2023-02-23
Primary completion: 2024-01-17
Completion: 2024-01-17

Publications

Bergman H, Henschke N, Arevalo-Rodriguez I, Buckley BS, Crosbie EJ, Davies JC, Dwan K, Golder SP, Loke YK, Probyn K, Petkovic J, Villanueva G, Morrison J. Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis. Cochrane Database Syst Rev. 2025 Nov 24;11(11):CD015364. doi: 10.1002/14651858.CD015364.pub2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cecolin	Vaccine	—	—
Subject	Gardasil	Vaccine	—	—

Indications

No indication recorded.